Loading...

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.

RummaGEO DrugPerturbations 2025 (Gene Set Library)

Project: Library of Integrated Network-based Cellular Signatures

Asset: Asset Page

Gene coverage: 18,693

Gene sets: 5,344

Download: https://cfde-drc.s3.amazonaws.com/LINCS/XMT/2025-06-25/RummaGEO_DrugPerturbations_2025.gmt

Description: A gene set library provided by LINCS

Analyze

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with RummaGEO DrugPerturbations 2025.

Gene sets

Label	Description
GSE158834 7 V 3 PALMITIC ACID HUMAN UP Gene Set (Entity type)	A gene set from RummaGEO DrugPerturbations 2025 provided by LINCS
GSE89154 1 V 3 PROSCILLARIDIN HUMAN DN Gene Set (Entity type)	A gene set from RummaGEO DrugPerturbations 2025 provided by LINCS
GSE120612 7 V 2 ETOPOSIDE HUMAN DN Gene Set (Entity type)	A gene set from RummaGEO DrugPerturbations 2025 provided by LINCS
GSE171837 0 V 1 BORTEZOMIB HUMAN UP Gene Set (Entity type)	A gene set from RummaGEO DrugPerturbations 2025 provided by LINCS
GSE118548 1 V 2 TRAMETINIB HUMAN UP Gene Set (Entity type)	A gene set from RummaGEO DrugPerturbations 2025 provided by LINCS
GSE235390 4 V 0 LURBINECTEDIN HUMAN DN Gene Set (Entity type)	A gene set from RummaGEO DrugPerturbations 2025 provided by LINCS
GSE163297 0 V 2 DOXORUBICIN HUMAN DN Gene Set (Entity type)	A gene set from RummaGEO DrugPerturbations 2025 provided by LINCS
GSE182680,GSE182683 10 V 3 DEXAMETHASONE HUMAN UP Gene Set (Entity type)	A gene set from RummaGEO DrugPerturbations 2025 provided by LINCS
GSE57871 11 V 12 VORINOSTAT HUMAN DN Gene Set (Entity type)	A gene set from RummaGEO DrugPerturbations 2025 provided by LINCS
GSE142210 9 V 1 PANOBINOSTAT HUMAN DN Gene Set (Entity type)	A gene set from RummaGEO DrugPerturbations 2025 provided by LINCS

GSE158834 7 V 3 PALMITIC ACID HUMAN UP
Gene Set (Entity type)
A gene set from RummaGEO DrugPerturbations 2025 provided by LINCS

GSE89154 1 V 3 PROSCILLARIDIN HUMAN DN
Gene Set (Entity type)
A gene set from RummaGEO DrugPerturbations 2025 provided by LINCS

GSE120612 7 V 2 ETOPOSIDE HUMAN DN
Gene Set (Entity type)
A gene set from RummaGEO DrugPerturbations 2025 provided by LINCS

GSE171837 0 V 1 BORTEZOMIB HUMAN UP
Gene Set (Entity type)
A gene set from RummaGEO DrugPerturbations 2025 provided by LINCS

GSE118548 1 V 2 TRAMETINIB HUMAN UP
Gene Set (Entity type)
A gene set from RummaGEO DrugPerturbations 2025 provided by LINCS

GSE235390 4 V 0 LURBINECTEDIN HUMAN DN
Gene Set (Entity type)
A gene set from RummaGEO DrugPerturbations 2025 provided by LINCS

GSE163297 0 V 2 DOXORUBICIN HUMAN DN
Gene Set (Entity type)
A gene set from RummaGEO DrugPerturbations 2025 provided by LINCS

GSE182680,GSE182683 10 V 3 DEXAMETHASONE HUMAN UP
Gene Set (Entity type)
A gene set from RummaGEO DrugPerturbations 2025 provided by LINCS

GSE57871 11 V 12 VORINOSTAT HUMAN DN
Gene Set (Entity type)
A gene set from RummaGEO DrugPerturbations 2025 provided by LINCS

GSE142210 9 V 1 PANOBINOSTAT HUMAN DN
Gene Set (Entity type)
A gene set from RummaGEO DrugPerturbations 2025 provided by LINCS

DISPLAY PER PAGE